- Telehealth Visits
- Insurance plan information
Hubert T. Kim, MD, PhD
Joint Replacement Surgery • Orthopedic Surgery- Telehealth Visits
- Insurance plan information
Hubert T. Kim, MD, PhD
Joint Replacement Surgery • Orthopedic Surgery- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Hubert Kim is an orthopedic surgeon and director of the UCSF Cartilage Repair and Regeneration Center at the UCSF Orthopaedic Institute. He specializes in treating arthritis and cartilage injuries specifically located in the knee, hip, shoulder or ankle.
Since 2011, Kim has been the James O. Johnston Endowed Chair in Orthopaedic Surgery Education. His research investigates the mechanisms involved in cell death after joint cartilage injury and ways to limit this process. His lab also studies using connective-tissue stem cells for bone and cartilage repair as well as for repair of muscle and nerve injuries.
Kim earned his medical degree at the Stanford University School of Medicine, where he also earned a doctorate in cancer biology. He completed a residency in orthopedic surgery at UCSF before joining the faculty in 1998.
Education & training
Board certification
- Orthopaedic Surgery, American Board of Orthopaedic Surgery
Residency
- Orthopaedic Surgery, UCSF Medical Center - OMAG
Internship
- General Surgery, UCSF Medical Center - OMAG
Degree
- MD, Stanford University School of Medicine
My expertise
Specialties
Treatments
- Knee Arthroplasty
- Total Knee Replacement
- Total Hip Replacement
- Hip Replacement
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22179%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22179%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.